No. of medications Type of medications First CSU episode Relapse of CSU
No. of Patients (% of total cohort) No. of Patients (% of total cohort)
1
Antihistamine regular dose
153 (61.2%) 10 (41.7%)
Antihistamine high dose
7 (2.8%) 2 (8.3%)
Steroids course
1 (0.4%)
0
Montelukast only
0
1 (4.2%)
Total
161 (64.4%) 13 (54.2%)
2
Antihistamine regular dose + Steroids
32 (12.8%) 2 (8.3%)
Antihistamine high dose + Steroids
9 (3.6%)
0
Antihistamine regular dose + Montelukast
2 (0.8%)
0
Antihistamine high dose + Montelukast
3 (1.2%) 2 (8.3%)
Montelukast + Omalizumab
0
1 (4.2%)
Total
46 (18.4%) 5 (20.8%)
3
Antihistamine high dose + Steroids + Montelukast
5 (2%)
0
Antihistamine high dose + steroids + Omalizumab
1 (0.4%)
0
Total
6 (2.4%)
0
4
Antihistamine high dose + Steroids + Montelukast + Omalizumab
0
2 (8.3%)
No record of medications
No record of medications
37 (14.8%) 4 (16.7%)
Total of patients Total of patients 250 24